Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK5

RBC: NEK5 · Substrate: MBP · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Avapritinib89.70.64
Ponatinib56.00.53
Fostamatinib52.80.61
Dabrafenib39.80.63
Pacritinib39.00.45
Pemigatinib35.20.72
Repotrectinib34.30.61
Neratinib33.60.60
Pazopanib30.20.67
Defactinib27.00.45
Pralsetinib26.10.64
Fedratinib25.50.58
Netarsudil18.60.68
Vemurafenib17.80.60
Alpelisib16.30.72

Known variants

No variants catalogued.
Open in new tab